These facilities are commissioned by Aurobindo's wholly own subsidiary: Lyfius Pharma Private Limited, Qule Pharma Private Limited, Eugia Steriles Private Limited and Auroactive Pharma Private Limited.
The company had earlier announced about the approval received from the MHRA for Liraglutide
First and only AKT inhibitor approved in Japan for breast cancer patients with specific biomarker alterations
Oscotec has successfully completed phase 2 study in patients with chronic ITP last year
Ukrainian marketing approvals for paclitaxel, oxaliplatin and irinotecan mark a significant milestone in the company’s global expansion strategy
Christoph Funke's extensive career includes leadership roles at organizations such as Fresenius Kabi and Strides Pharma Science
Launch of Indian public health standards for Ayush healthcare facilities
Survodutide has potential to become best-in-class treatment for metabolic dysfunction-associated steatohepatitis
Both the Ministries signed MoU for anaemia control among adolescent girls using Ayurveda interventions
The project aims at screening the general health condition of the students enrolled in classes 6th to 12th.
Subscribe To Our Newsletter & Stay Updated
